参考文献/References:
[1] Ormazabal V,Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease[J].Cardiovasc Diabetol,2018,17(1):122.
[2] Samuel VT, Shulman GI.Integrating mechanisms for insulin resistance: common threads and missing links[J].Cell,2012,148(5): 852-871.
[3] Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux[J]. J Clin Investig,2016,126(1):12-22.
[4] Nandipati KC, Subramanian S, Agrawal DK.Protein kinases: mechanisms and downstream targets ininflammationmediated obesity andinsulin resistance[J].Mol Cell Biochem,2017,426(1-2): 27-45.
[5] Tang K, Pasqua T, Biswas A,et al. Muscle injury, impaired muscle function and insulin resistance in Chromogranin A-knockout mice[J]. J Endocrinol,2017,232(2):137-153.
[6] Shrestha S, Singh VK, Sarkar SK,et al. Effect of sub-toxic chlorpyrifos on redox sensitive kinases and insulin signaling in rat L6 myotubes[J]. J Diabetes Metab Disord,2018,17(2):325-332.
[7] Rima Chaudhuri, James R. Krycer, Daniel J. et al.The transcriptional response tooxidative stressis part of, but not sufficient for,insulin resistancein adipocytes[J].Sci Rep,2018,8(1): 1774.
[8] Lee Y, Fluckey JD, Chakraborty S, et al. Hyperglycemia and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle[J]. FASEB J,2017,31(7):2744-2759.
[9] De Matteis S, Scarpi E, Granato AM,et al.Role of SIRT-3, p-mTOR and HIF-1α in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin[J].Int J Mol Sci,2019,20(6).pii:E1503.
[10] Wang Z, Liu Y, Li Q,et al. Preoperative oral carbohydrate improved postoperative Insulin resistance in rats through the PI3K/AKT/mTOR pathway[J].Med Sci Monit,2015,21:9-17.
[11] Hubal MJ, Nadler EP, Ferrante SC, et al. Circulating adipocyte-derived exosomal microRNA associated with decreased insulin decreased insulin resistance after gastric bypass[J].Obesity (Silver Spring),2017,25(1):102-110.
[12] Jones A, Danielson KM, Benton MC, et al. MiRNA signatures of insulin resistance in obesity[J].Obesity (Silver Spring),2017,25(10):1734-1744.
[13] O’Neill S, Larsen MB, Gregersen S,et al.MiR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome[J].Oncotarget,2018,9(10): 9379-9390.
[14] Chuang TY, Wu HL, Chen CC, et al.MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue[J].J Diabetes Res,2015,2015:943659.
[15] Pisano F,Altomare C,Cervio E,et al.Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation[J].Stem Cells,2015,33(4):1187-1199.
[16] Sucharita S, Ashwini V,Prabhu JS,et al. The role of circulating microRNA in the regulation of beta cell function and insulin resistance among indians with type 2 diabetes[J]. Indian J Endocrinol Metab,2018,22(6):770-773.
[17] Bakar MH, Sarmidi MR, Kai CK, et al.Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways[J].Int J Mol Sci,2014,15(12):22227-22257.
[18] Wang CH, Wei YH.Role of mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in the pathophysiology of insulin resistance and type 2 diabetes[J].J Biomed Sci,2017,24(1):70.
[19] Lepretti M, Martucciello S,Burgos Aceves MA,et al.Omega-3 fatty acids and insulin resistance: focus on the regulation of mitochondria and endoplasmic reticulum stress[J].Nutrients,2018,10(3).pii:350.
[20] Lantier L, Williams AS, Williams IM, et al.SIRT3 is crucial for maintaining skeletal muscleInsulin action and protects against severe insulin resistance in high-fat-fed mice[J].Diabetes,2015,64(9):3081-3092.
[21] Ben-Dov IZ, Bursztyn M. Associations of arterial stiffness indices with measures of insulin resistance and renal sodium reabsorption[J]. Am J Hypertens,2019,32(9):810-812.
[22] Caruso FR, Junior JC,Mendes RG,et al. Hemodynamic and metabolic response during dynamic and resistance exercise in different intensities:a cross-sectional study on implications of intensity on safety and symptoms in patients with coronary disease[J].Am J Cardiovasc Dis,2016,6(2):36-45.
[23] Karcz-Socha I, Zwirska-Korczala K,Zembala M,et al.Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients[J].Obes Facts,2011,4(5):386-392.
[24] Choo MS, Choi SR, Han JH,et al.et al.Association of insulin resistance with near peak bone mass in the femur and lumbar spine of Korean adults aged 25-35: The Korean National Health and Nutrition Examination Survey 2008-2010[J].PLoS One,2017,12(7):e0177311.
[25] Yamazoe M, Hisamatsu T, Miura K,et al. Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components[J]. Arterioscler Thromb Vasc Biol,2016,36(8):1703-1708.
[26] Posadas-Sánchez R, Posadas-Romero C,Cardoso-Salda?a G,et al. Serum magnesium is inversely associated with coronary artery calcification in the Genetics of Atherosclerotic Disease (GEA) study[J].Nutr J,2016,15:22.
[27] Nichols TC,Merricks EP,Bellinger DA,et al.Oxidized LDL and fructosamine associated with severity of coronary artery atherosclerosis in insulin resistant pigs fed a high fat/high NaCl diet[J].PLoS One,2015,10(7):e0132302.
[28] Mellbin LG, Wang A, Rydén L.Clinical implications of cardiovascular outcome trials in type?2?diabetes[J].Herz,2019,44(3):192-202.
[29] Sun S, Tan P, Huang X, et al. Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes[J].J Biol Chem,2018,293(7): 2383-2394.
[30] Pereira S, Park E, Mori Y, et al. FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress[J].Am J Physiol Endocrinol Metab,2014,307(1):E34-E46.
[31] Ma S, Feng J, Zhang R,et al.SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice[J].Oxid Med Cell Longev,2017,2017:4602715.
[32] 吴洁,秦兴华,侯作旭,等. miR-494-3p通过下调胰岛素受体底物-1促糖尿病大鼠心肌细胞胰岛素抵抗[J].生理学报,2019,71(2):271-278.
[33] Velez M, Kohli S, Sabbah HN. Models of insulin resistance and heart failure[J]. Heart Fail Rev,2014,19(1):1-13.
[34] Riehle C, Abel ED.Insulin signaling and heart failure[J]. Circ Res,2016,118(7):1151-1169.
[35] Cozzolino D,Grandone A,Cittadini A,et al.Subclinical myocardial dysfunction and cardiac autonomic dysregulation are closely associated in obese children and adolescents: the potential role of insulin resistance[J].PLoS One,2015,10(4):e0123916.
[36] Jackson CA, Jones NR, Walker JJ, et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland[J]. Diabetologia,2012,55:2938-2945.
相似文献/References:
[1]陈炜,许贞蓉.表观遗传学与代谢性心血管疾病的研究进展[J].心血管病学进展,2019,(6):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
CHEN Wei,XU Zhenrong.Epigenetics and Cardiometabolic Disease[J].Advances in Cardiovascular Diseases,2019,(9):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
[2]占小锋 张长磊 李刚.β肾上腺素受体阻滞剂对甘油三酯代谢的影响及其作用机制的阐述[J].心血管病学进展,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
ZHAN Xiaofeng,ZHANG Changlei,LI Gang.Effect of -adrenergic Receptor Blockers on Triglyceride Metabolism and Mechanism[J].Advances in Cardiovascular Diseases,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
[3]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(9):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[4]任蕾 夏芳芳 戴红艳.血管生成素样蛋白6在心血管病方面的研究进展[J].心血管病学进展,2020,(4):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
REN Lei,XIA FangFang,DAI HongYan.Relationship Between ANGPTL6 and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(9):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
[5]杨晓倩 秦莉 张艺文 童兰 汪汉.糖皮质激素与心血管疾病[J].心血管病学进展,2020,(4):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Glucocorticoid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(9):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
[6]樊德慧 金娟 韩宇博 田苗 刘莉.利钠肽与代谢综合征的研究进展[J].心血管病学进展,2020,(10):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
FAN Dehui,JIN Juan,HAN Yubo,et al.Research Progress of Natriuretic Peptide and Metabolic Syndrome[J].Advances in Cardiovascular Diseases,2020,(9):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
[7]廖丽萍 周跟东 张晓红.血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展[J].心血管病学进展,2020,(11):1189.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[8]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[9]蔡薇 杨堰焯 刘昊凌.甘油三酯葡萄糖乘积指数与糖尿病血管病变的研究进展[J].心血管病学进展,2022,(3):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
CAI Wei,YANG Yanzhuo,LIU Haoling.Triglyceride-Glucose Index and Diabetic Vascular Disease[J].Advances in Cardiovascular Diseases,2022,(9):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[10]谭思华 周晓莉.非酒精性脂肪肝与冠状动脉粥样硬化及炎症的研究进展[J].心血管病学进展,2023,(5):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
TAN Sihua,ZHOU Xiaoli.Association of Non-Alcoholic Fatty Liver Disease with Coronary Atherosclerosis and Inflammation[J].Advances in Cardiovascular Diseases,2023,(9):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]